Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the next generation of drugs targeting the interaction between TCR and Nck, which is responsible for T-cell activation. Specific control over T-cells through TCR, provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases.
View Top Employees from Artax Biopharma Inc| Website | http://www.artaxbiopharma.com |
| Revenue | $1 million |
| Funding | $13.3 million |
| Employees | 13 (8 on RocketReach) |
| Founded | 2013 |
| Address | 1 Broadway Fl 14, Cambridge, Massachusetts 02142, US |
| Phone | (617) 368-0676 |
| Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering, Therapeutics |
| Competitors | ChemoCentryx, GENFIT, PaxVax, Inc., VBI Vaccines Inc., VGX Pharmaceuticals |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies |
Looking for a particular Artax Biopharma Inc employee's phone or email?
Artax Biopharma Inc Questions
The Artax Biopharma Inc annual revenue was $1 million in 2024.
Joe Lobacki is the CEO of Artax Biopharma Inc.
8 people are employed at Artax Biopharma Inc.
Artax Biopharma Inc is based in Cambridge, Massachusetts.
The NAICS codes for Artax Biopharma Inc are [54, 541713, 5417, 54171, 541].
The SIC codes for Artax Biopharma Inc are [87, 873].
Top Artax Biopharma Inc Employees
-
5+5+
-
45+
-
5+5+
-
5+5
-
45+
-
ViewSuzanne Crowley
VP Clinical Operations at Artax Biopharma Inc
Sebastian, Florida, United States44 -
23
Related Companies
